IL-1α, IL-1β, and IL-18 are proinflammatory molecules involved in atherosclerosis disease progression [5], while the anti-inflammatory cytokines TGF-β, IL-33, IL-10, and IL-13 function in the reduction of atherogenesis in cardiovascular disorders [4, 6]. Here, IL18 is linked to atherosclerosis.